What is the Futurechem Co., Ltd. stock price forecast?

Futurechem Co., Ltd. is currently trading at ₩12,500. View real-time AI analysis on Alpha Lenz.

What is Futurechem Co., Ltd. insider trading activity?

View the latest insider trading data for Futurechem Co., Ltd. on Alpha Lenz.

What is Futurechem Co., Ltd.'s P/E ratio?

Futurechem Co., Ltd.'s P/E ratio is -24.9.

Futurechem Co., Ltd.

KRX · 220100

₩12,500+910(+7.85%)Market closed

Ask about Futurechem Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Futurechem Co., Ltd. trades at a P/E of -24.9 (undervalued) with modest ROE of -20.6%. 3Y revenue CAGR of 14.1% highlights clear growth momentum.”

Ask for details →

Company Overview

Futurechem Co., Ltd. is a prominent pharmaceutical company specializing in the research and development of radiopharmaceuticals and diagnostic imaging agents. The company's primary function is to innovate in the field of nuclear medicine, providing advanced medical solutions that enhance diagnostic precision and treatment effectiveness. Futurechem is known for developing radiotracers used in positron emission tomography (PET), which play a crucial role in detecting and monitoring various diseases, including cancer. With a strong focus on biotechnology and pharmaceutical advancements, Futurechem Co., Ltd. significantly impacts the healthcare industry by contributing to improved patient outcomes and supporting the global demand for innovative medical technologies. Its strategic developments and research initiatives position it as a key player in the expanding market of radiopharmaceuticals, underscoring its importance in modern medical diagnostics and therapeutic solutions.

CEO지대윤

Websitehttps://www.futurechem.co.kr

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees68

Company Statistics

FY 2025

Profile

₩280,342,750,000Market Cap

₩18,670,511,670Revenue

22.43MShares Out

68Employees

Margins

23.06%Gross

-11.97%EBITDA

-41.51%Operating

-59.38%Pre-Tax

-60.03%Net

Valuation

-24.92P/E

5.13P/B

15.02EV/Sales

-126.93EV/EBITDA

-25.59P/FCF

Growth (CAGR)

14.09%Rev 3Yr

11.13%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-15.05%ROA

-20.64%ROE

-13.49%ROIC

Financial Health

₩4,338,487,000Cash & Cash Equivalents

₩15,360,923,450Net Debt

35.93%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Futurechem Co., Ltd. trades at a P/E of -24.9 (undervalued) with modest ROE of -20.6%. 3Y revenue CAGR of 14.1% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Futurechem Co., Ltd. (ticker: 220100) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 68 employees. Market cap is $280.3B.

The current price is ₩12,500 with a P/E ratio of -24.92x and P/B of 5.13x.

ROE is -20.64% and operating margin is -41.51%. Annual revenue is $18.7B.